During the past decade, Zeid Women's Health Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zeid Women's Health Center" #1 collaborator was "Children's Hospital of Philadelphia" with 1 trials as a collaborator, "George Washington University" with 1 trials as a collaborator, "Montefiore Medical Center" with 1 trials as a collaborator and "University of California, San Francisco" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Zeid Women's Health Center" are "1p36 Deletion Syndrome" (1 trials), "22q11 Deletion Syndrome" (1 trials), "Angelman Syndrome" (1 trials), "Cri-du-Chat Syndrome" (1 trials) and "DiGeorge Syndrome" (1 trials). Many other conditions were trialed in "Zeid Women's Health Center" in a lesser frequency.

Most popular intervention types in "Zeid Women's Health Center" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "DySIS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zeid Women's Health Center" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Zeid Women's Health Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Zeid Women's Health Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zeid Women's Health Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".